Literature DB >> 8392095

Alloreactive cytotoxic T lymphocytes generated in the presence of viral-derived peptides show exquisite peptide and MHC specificity.

M A Alexander-Miller1, K Burke, U H Koszinowski, T H Hansen, J M Connolly.   

Abstract

The nature of alloreactivity to MHC molecules has been enigmatic, primarily because of the observation that allogeneic responses are considerably stronger than syngeneic responses. To better determine the specificity potential of allogeneic responses, we have generated alloreactive CTL specific for exogenous, viral-derived peptide ligands. This approach allowed us to critically evaluate both the peptide- and MHC-specificity of these alloreactive T cells. Exploiting the accessibility of the H-2Ld class I molecule for exogenous peptide ligands, alloreactive CTL were generated that are specific for either murine cytomegalovirus (MCMV) or lymphocytic choriomeningitis virus (LCMV) peptides bound by Ld alloantigens. Peptide specificity was initially observed in bulk cultures of alloreactive CTL only when tested on peptide-sensitized T2.Ld target cells that have defective presentation of endogenous peptides. Subsequent cloning of bulk alloreactive CTL lines generated to MCMV yielded CTL clones that had exquisitely specific MCMV peptide recognition requirement. All of the MCMV/Ld alloreactive CTL clones were also exquisitely MHC-specific in that none of the CTL clones lysed targets expressing MCMV/Lq complexes, even though Lq differs from Ld by only six amino acid residues and Lq also binds the MCMV peptide. This observation clearly demonstrates that alloreactive CTL are capable of the same degree of specificity for target cell recognition as are syngeneic CTL in MHC-restricted responses.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392095

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Mechanism of binding of surfactant protein D to influenza A viruses: importance of binding to haemagglutinin to antiviral activity.

Authors:  K L Hartshorn; M R White; D R Voelker; J Coburn; K Zaner; E C Crouch
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

Review 2.  Homeostatic T cell proliferation as a barrier to T cell tolerance.

Authors:  Somia P Hickman; Laurence A Turka
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

3.  The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection.

Authors:  A M Cooper; A D Roberts; E R Rhoades; J E Callahan; D M Getzy; I M Orme
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

4.  Constitutive tyrosine phosphorylation of the T-cell receptor (TCR) zeta subunit: regulation of TCR-associated protein tyrosine kinase activity by TCR zeta.

Authors:  N S van Oers; W Tao; J D Watts; P Johnson; R Aebersold; H S Teh
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

5.  Induction of interleukin-12 (IL-12) by recombinant glycoprotein gp120 of human immunodeficiency virus type 1 in human monocytes/macrophages: requirement of gamma interferon for IL-12 secretion.

Authors:  L Fantuzzi; S Gessani; P Borghi; B Varano; L Conti; P Puddu; F Belardelli
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

6.  Induction of beta interferon by human immunodeficiency virus type 1 and its gp120 protein in human monocytes-macrophages: role of beta interferon in restriction of virus replication.

Authors:  S Gessani; P Puddu; B Varano; P Borghi; L Conti; L Fantuzzi; F Belardelli
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

Review 7.  Allo-reactive T cells for the treatment of hematological malignancies.

Authors:  J H F Falkenburg; I Jedema
Journal:  Mol Oncol       Date:  2015-10-24       Impact factor: 6.603

8.  Specific prolongation of allograft survival by a T-cell-receptor-derived peptide.

Authors:  J A Goss; M A Alexander-Miller; J Gorka; M W Flye; J M Connolly; T H Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

9.  Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody.

Authors:  M Zahidunnabi Dewan; Ashley E Galloway; Noriko Kawashima; J Keith Dewyngaert; James S Babb; Silvia C Formenti; Sandra Demaria
Journal:  Clin Cancer Res       Date:  2009-08-25       Impact factor: 12.531

10.  Presence of immunoreactive corticotropin releasing hormone in thyroid lesions.

Authors:  C D Scopa; G Mastorakos; T C Friedman; M Melachrinou; M J Merino; G P Chrousos
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.